Where do I report vaccine adverse reaction(s)?
Appendix 1. Common abbreviations and/or acronyms ————————————– FAQ for the Lyme Disease Newsgroup Part 0: Administrative Issues 0.00 Introduction Information in the Lyme disease FAQ, version 1.0, January 15, 2000, was compiled by Milo7 (Milo7@aol.com), Art Doherty (doherty@utech.net), and Jonathan R. Strong (JRS@strong.com), and was created on behalf of the Lyme disease newsgroup: sci.med.diseases.lyme. Readers may redistribute or quote this document for non-commercial purposes provided that they include: an attribution to sci.med.diseases.lyme; the FAQ’s version number; and the website where this FAQ may be retrieved (see Section 0.03). For any other use, please contact: Milo7@aol.com, doherty@utech.net, or JRS@strong.com.\0 This document answers Frequently Asked Questions (FAQ) about Lyme Disease (LD). The newsgroup sci.med.diseases.lyme is intended for discussion about many aspects of Lyme disease, as experienced by patients, their caregivers, friends and fa
